Joseph Papa
CEO
CEO
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Emergent BioSolutions Inc. (EBS) | President, Chief Executive Officer and Director | $1,037,385 | $5,321,147 |
| 2024 | Emergent BioSolutions Inc. (EBS) | President, Chief Executive Officer and Director | $800,000 | $5,862,562 |
| 2022 | Bausch & Lomb Corp (BLCO) | Chief Executive Officer | $1,600,000 | $19,781,761 |
| 2021 | Bausch & Lomb Corp (BLCO) | Chief Executive Officer | $1,600,000 | $22,889,137 |
| 2021 | Bausch Health Companies Inc. (BHC) | Former Chief Executive Officer | $1,600,000 | $22,889,137 |
| 2020 | Bausch & Lomb Corp (BLCO) | Chief Executive Officer | $1,526,539 | $14,119,361 |
| 2020 | Bausch Health Companies Inc. (BHC) | Former Chief Executive Officer | $1,526,539 | $14,119,361 |
| 2019 | Bausch Health Companies Inc. (BHC) | Chief Executive Officer | $1,500,000 | $17,141,646 |
| 2018 | Bausch Health Companies Inc. (BHC) | Chief Executive Officer | $1,500,000 | $14,741,050 |
| 2017 | Bausch Health Companies Inc. (BHC) | Chief Executive Officer | $1,500,000 | $4,895,108 |
Earnings-call appearances
-
Emergent BioSolutions Inc. Q3 FY2025 Earnings Call2025-10-29
Emergent BioSolutions Inc. (EBS)
-
Emergent BioSolutions Inc. Q2 FY2025 Earnings Call2025-08-06
Emergent BioSolutions Inc. (EBS)
-
Emergent BioSolutions Inc. Q4 FY2024 Earnings Call2025-03-03
Emergent BioSolutions Inc. (EBS)
-
Emergent BioSolutions Inc. Q1 FY2024 Earnings Call2024-05-01
Emergent BioSolutions Inc. (EBS)
-
Bausch & Lomb Corp Q3 FY2022 Earnings Call2022-11-02
Bausch & Lomb Corp (BLCO)
-
Bausch & Lomb Corp Q2 FY2022 Earnings Call2022-08-04
Bausch & Lomb Corp (BLCO)
-
Bausch Health Companies Inc. Q2 FY2020 Earnings Call2020-08-06
Bausch Health Companies Inc. (BHC)